PHARMACOKINETIC CHARACTERISTICS OF N7-SUBSTITUTED THEOPHYLLINE DERIVATIVES AND THEIR INTERACTION WITH QUINOLONE IN RATS

被引:9
作者
HASEGAWA, T [1 ]
NADAI, M [1 ]
APICHARTPICHEAN, R [1 ]
MURAOKA, I [1 ]
NABESHIMA, T [1 ]
TAKAGI, K [1 ]
机构
[1] NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 2,NAGOYA,AICHI 466,JAPAN
关键词
D O I
10.1002/jps.2600801012
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Disposition of diprophylline (DPP) and proxyphylline (PXP) and the effect of enoxacin on their disposition were investigated in rats. Concentrations of the two drugs in plasma and urine were measured by HPLC. The pharmacokinetic parameters of the two drugs were estimated by model-independent methods. Although the chemical structures of the two drugs were observed. Total body clearance (CL(T)) of DPP was 1.77 L/h/kg, which was sevenfold greater than that of PXP (0.26 L/h/kg). Diprophylline was excreted in an almost completely unchanged form in the urine, but only 50% of PXP was excreted. However, no binding of either drug to proteins in rat plasma was observed. The DPP renal clearance (CL(R)) was 1.75 L/h/kg, approximately 13-fold the CL(R) for PXP (0.13 L/h/kg) and sevenfold the rat glomerular filtration rate. This study indicates that in rats, DPP is mainly excreted by active tubular secretion and that renal tubular reabsorption contributes to renal excretion of PXP with glomerular filtration. No significant changes in any pharmacokinetic parameters of the two drugs were observed when they were coadministered with enoxacin, compared with the drug administered alone, suggesting that enoxacin had no effect on the pharmacokinetics of either drug.
引用
收藏
页码:962 / 965
页数:4
相关论文
共 29 条
  • [1] ANDERSSON KE, 1985, ANTI ASTHMA XANTHINE, P223
  • [2] STRUCTURE-PHARMACOKINETIC RELATIONSHIPS AMONG THE N1-ALKYLXANTHINE, N3-ALKYLXANTHINE IN RATS
    APICHARTPICHEAN, R
    HASEGAWA, T
    NADAI, M
    KUZUYA, T
    NABESHIMA, T
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (04) : 262 - 269
  • [3] ENOXACIN - A POTENT INHIBITOR OF THEOPHYLLINE METABOLISM
    BECKMANN, J
    ELSASSER, W
    GUNDERTREMY, U
    HERTRAMPF, R
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 33 (03) : 227 - 230
  • [4] CAMPBELL ME, 1987, DRUG METAB DISPOS, V15, P237
  • [5] EFFECT OF QUINOLONES ON CAFFEINE DISPOSITION
    CARBO, ML
    SEGURA, J
    DELATORRE, R
    BADENAS, JM
    CAMI, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (03) : 234 - 240
  • [6] INHIBITION OF DRUG-METABOLISM BY QUINOLONE ANTIBIOTICS
    EDWARDS, DJ
    BOWLES, SK
    SVENSSON, CK
    RYBAK, MJ
    [J]. CLINICAL PHARMACOKINETICS, 1988, 15 (03) : 194 - 204
  • [7] GEORGE HB, 1988, CLIN PHARMACOL THER, V44, P35
  • [8] PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING - PRINCIPLES AND APPLICATIONS
    GERLOWSKI, LE
    JAIN, RK
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (10) : 1103 - 1127
  • [9] INHIBITION OF THEOPHYLLINE CLEARANCE BY COADMINISTERED OFLOXACIN WITHOUT ALTERATION OF THEOPHYLLINE EFFECTS
    GREGOIRE, SL
    GRASELA, TH
    FREER, JP
    TACK, KJ
    SCHENTAG, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (03) : 375 - 378
  • [10] DIFFERENTIAL-EFFECTS OF CIMETIDINE ON THEOPHYLLINE METABOLIC PATHWAYS
    GRYGIEL, JJ
    MINERS, JO
    DREW, R
    BIRKETT, DJ
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (03) : 335 - 340